Tango Therapeutics, Inc. · NASDAQ:TNGX
Newcomb Jessica sold 8,200 Tango Therapeutics, Inc. shares (Form 4)
Traded Sep 22, 2026 · Filed Sep 24, 2026
On Sep 22, 2026, Newcomb Jessica (Principal Accounting Officer) sold 8,200 Tango Therapeutics, Inc. shares at an average US$24.22 for US$199K under a trading plan, leaving 59,121 shares. Filed Sep 24, 2026 (Form 4).
- Sold
- 8,200 shares
- Price
- US$24.22 average (US$22.80 to US$25.17)
- Value
- US$199K
- Holding after
- 59,121 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Principal Accounting Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 22, 2026 | Common Stock | Sale | 700 | US$22.80 | 66,621 | Direct |
| Sep 22, 2026 | Common Stock | Sale | 5,100 | US$23.97 | 61,521 | Direct |
| Sep 22, 2026 | Common Stock | Sale | 2,400 | US$25.17 | 59,121 | Direct |
Source
Related
- Tango Therapeutics, Inc.
- Newcomb Jessica
- Tango Therapeutics, Inc. shareholders
- Form 4 · Crystal Adam · Oct 5, 2026
- Form 4 · Crystal Adam · Sep 3, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G · Goldman Sachs Group Inc · Aug 14, 2026
- Schedule 13G/A · Nextech Crossover I GP S.a. r.l. · Aug 14, 2026